Experts say the recent pause on COVID-19 vaccine and treatment trials aren’t unusual, but rather show scientific safety processes are working.
Author: Karen Weintraub and Elizabeth Weise, USA TODAY
The sprint to create a COVID-19 vaccine started in January. The finish line awaits.
Drug developers confronting the coronavirus pandemic are fueled by coffee, competitiveness and a chance to protect the world.
With Trump promising a COVID-19 vaccine ‘very soon,’ industry developers pledge to keep politics out of science
With the November election approaching, nine vaccine developers promise to fully vet their COVID-19 candidate vaccines before seeking FDA approval.